Financial news
Headlines from permitted publisher feeds and official institutions. Similar reports are grouped into one story with a source count; every item links to the original.
- Earnings call transcript: HORNBACH Group posts solid Q2 2026 sales growth
- Earnings call transcript: HORNBACH posts solid H1 2026 results, keeps guidance cautious
- Defence Therapeutics appoints Sherry Aulin to board
- Exclusive-Anthropic leaders to control AI lab via ’Founder LLC’ to promote public good over market forces
- FTSE 100 today: Stocks edge up as UK shop price inflation slows
- Bernstein downgrades Pan Pacific International stock rating on margin pressure
- Natural Gas stalls at $3.129 with bearish MACD cross: Live levels
- China automaker FAW to explore broader cooperation with GAC after JV stake deal
- Bitcoin consolidates below $85K resistance: Live levels
- Brent Oil nears double top breakdown at $96.20: Live levels
- The stock market usually booms in the November-to-April stretch. This indicator suggests otherwise.
Jim Paulsen thinks lagged indicators suggest the usual ‘best buying season’ for stocks may not be applicable this time and backtesting his model to 1970 shows meagre returns.
- GTCO declares N1.00 interim dividend per share
- Cytokinetics CEO Robert Blum sells $490,949 in stock
- Roth/MKM initiates Nautilus Biotechnology stock with buy rating
- Roth/MKM initiates Rapid Micro Biosystems stock with buy rating
- Exclusive-Colombia holds IMF financing talks as fiscal strain mounts, sources say
- Japan stocks lower at close of trade; Nikkei 225 down 0.47%
- Stadler Rail names Philipp Brunner CEO from 2027, targets profit growth
- Thalia Therapeutics receives China patent for AML drug miRisten
- Stifel upgrades STAAR Surgical stock rating on China growth outlook